A Phase II Study of Three-Weekly Docetaxel and Weekly Trastuzumab in HER2-Overexpressing Advanced Breast Cancer

Publisher： Karger

E-ISSN： 1423-0232|66|1|38-45

ISSN： 0030-2414

Source： Oncology, Vol.66, Iss.1, 2004-03, pp. : 38-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-Dose 5-Fluorouracil / Folinic Acid in Combination with Three-Weekly Mitomycin C in the Treatment of Advanced Gastric Cancer. A Phase II Study

By  

Oncology Research and Treatment, Vol. 25, Iss. 3, 2002-07 ,pp. : 255-260

Karger

Access to resources Recommend Favorite

Weekly Administration of Gemcitabine Plus Docetaxel in Patients with Advanced Breast Cancer: A Phase 1 Study

By  

Oncology, Vol. 62, Iss. 1, 2002-01 ,pp. : 33-38

Karger

Access to resources Recommend Favorite

Weekly Combination of Docetaxel and Vinorelbine in Metastatic Breast Cancer: A Phase I/II Study

By  

Oncology, Vol. 67, Iss. 3-4, 2004-11 ,pp. : 257-261

Karger

Access to resources Recommend Favorite

Weekly Docetaxel and Gemcitabine as First-Line Treatment for Metastatic Breast Cancer: Results of a Multicenter Phase II Study

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 438-445

Karger

Access to resources Recommend Favorite

Weekly Docetaxel in Pretreated Metastatic Breast Cancer Patients: A Phase I-II Study

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 356-363

Karger

Access to resources Recommend Favorite